Quote | Options | News | Analyst Ratings

Matrixx Initiatives (MTXX)
Quote as of 9:51 AM ET 07/29/2010 (NASDAQ GS)
Last: 4.75 Change: $0.06 Percent Change: 1.28 Volume: 1,979
Matrixx Initiatives, Inc. develops, produces, markets and sells over-the-counter (OTC) healthcare products with an emphasis on those that utilize delivery systems. Through its subsidiary, Zicam, LLC, the Company markets and sells products under the Zicam brand. The Company?s product offerings include Cold Remedy Nasal; Cold Remedy Oral; Allergy/Sinus; Cough and Multi-Symptom, Antacid and other cough/cold. The Company has sales in one business segment, over-the-counter pharmaceuticals and dietary supplements.
Latest News
6:49:00 PM 7/28/2010
Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 First Quarter Financial Results
SCOTTSDALE, Ariz., July 28, 2010 /PRNewswire via COMTEX/ -- Matrixx Initiatives, Inc. (MTXX), an over-the-counter healthcare company, announced today that financial results for the fiscal 2011 first quarter ended June 30, 2010, will be released after the market closes on Tuesday, August 3, 2010. An earnings conference call will be held the following morning on Wednesday, August 4, 2010 at 11:00 AM ET.
9:30:00 PM 6/30/2010
Burns & Levinson LLP Files Class Action Lawsuit Against Matrixx Initiatives, Inc., Zicam L.L.C., Botanical Laboratories, Inc. and Costco Wholesale Corporation
BOSTON, Jun 30, 2010 (BUSINESS WIRE) -- Burns & Levinson LLP today announced that a Massachusetts man filed a class action lawsuit in U.S. District Court in Boston, claiming injuries including loss of sense of smell and diminished sense of taste as a result of using Zicam Cold Remedy Gel.
12:59:00 PM 5/19/2010
Matrixx Initiatives, Inc. Names William J. Barba Vice President of Finance and Accounting, and Treasurer
SCOTTSDALE, Ariz., May 19, 2010 /PRNewswire via COMTEX/ -- Matrixx Initiatives, Inc. (MTXX), an over-the-counter healthcare company that develops and markets Zicam(R) products, today announced that Matrixx's Board of Directors has named William J. Barba as Vice President of Finance and Accounting, and Treasurer effective May 6, 2010.
4:01:00 PM 5/10/2010
Matrixx Initiatives, Inc. Reports Fiscal 2010 Fourth Quarter and Full-Year Results
SCOTTSDALE, Ariz., May 10, 2010 /PRNewswire via COMTEX/ -- Matrixx Initiatives, Inc. (MTXX), an over-the-counter healthcare company that develops and markets Zicam(R) products that provide consumers with "better ways to get better(R)," today announced financial results for its fourth quarter and fiscal year ended March 31, 2010.
2:38:00 PM 5/4/2010
Matrixx Initiatives, Inc. Sets Time for Discussion of Fourth Quarter and Fiscal 2010 Financial Results
SCOTTSDALE, Ariz., May 4, 2010 /PRNewswire via COMTEX/ -- Matrixx Initiatives, Inc. (MTXX), an over-the-counter healthcare company, announced today that financial results for the fiscal 2010 fourth quarter and year ended March 31, 2010, will be released after the market closes on Monday, May 10, 2010. An earnings conference call will be held the following morning on Tuesday, May 11, 2010 at 11:00 AM ET.
12:45:00 PM 6/23/2009
Drug stocks edge higher; Matrixx tumbles
Drug stocks edged into positive territory, echoing the broader market, while shares of Matrixx tumbled further on regulatory woes.
- Sponsored Advertisement -
OptionsBuddy.com's covered call data is provided for information purposes only and should not be used or construed as an indicator of future performance. The information is not a solicitation, an offer to buy or sell, or a recommendation for any security. OptionsBuddy.com does not guarantee the accuracy or completeness of the information, or the suitability or potential value of any particular investment. Request a prospectus before investing. The term 'play' refers to placing a trade order. Returns on Investment (ROI) are based upon the option bid and the stock last. OTM ROI's do not take into account commission costs or loss of profit from options being excersized.
Copyright © 2006-2010 BuddyBuilder Software. All rights reserved.